H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares trading hands.
H. Lundbeck A/S Stock Performance
The stock has a market capitalization of $21.91 billion, a PE ratio of 25.00 and a beta of 0.68. The company has a quick ratio of 0.71, a current ratio of 1.15 and a debt-to-equity ratio of 0.32. The stock has a fifty day moving average of $22.00 and a 200-day moving average of $22.00.
About H. Lundbeck A/S
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
See Also
- Five stocks we like better than H. Lundbeck A/S
- Do ETFs Pay Dividends? What You Need to Know
- Energy Transfer: Powering Data With Dividends and Diversification
- What Investors Need to Know to Beat the Market
- Qualcomm Stock Is Coiling for a Breakout
- What is the Australian Securities Exchange (ASX)
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
